Kevin Price, President-Pharmathene UK, Ltd at PHARMATHENE, INC (PIP), bought 2,500 shares at $0.95 ($2K) on 2008-11-19, disclosed to the SEC on 2008-11-20.
Open-market purchase of $2k PIP by President-Pharmathene UK, Ltd. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.